Just 13 years after the CRISPR gene editing technique was described, the first medical treatment has been approved. On 15 November, the UK’s Medicines and Healthcare products Regulatory Agency authorised a treatment that can effectively cure sickle cell disease and transfusion-dependent beta thalassemia for people aged 12 and over. The US and European Union are expected to approve it soon too.
It’s a momentous step forward – and it’s just the start. The treatment, called Casgevy, is based on a first-generation …
Source link : https://www.newscientist.com/article/2403426-sickle-cell-crispr-cure-is-the-start-of-a-revolution-in-medicine/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=health
Publish date : 2023-11-16 14:41:19
Copyright for syndicated content belongs to the linked Source.